VHH domain of alpaca IgG2b/2c fused to Human IgG1 Fc(mutation)
Purification Method
Immunogen affinity purified.
Application Dilution
ELISA
1:4,000-1:10,000
FC
1:200-1:1,000
Target
Function
Anti-Claudin-18.2, AlpHcAbs® Human antibody is designed for detecting human Claudin-18.2 specifically. Anti-Claudin-18.2, AlpHcAbs® Human antibody is recombinant VHH domain of alpaca IgG2b/2c fused to Human IgG1 Fc. Based on ELISA, Anti-Claudin-18.2, AlpHcAbs® Human antibody reacts with human Claudin-18.2, and has reactivity with cynomolgus Claudin-18.2.
Advantages of using an Alpaca Recombinant Secondary 1. Smaller size Nanobodies are 1/10 the size of a traditional antibody (~15 kDa unconjugated). This means that the nanobody can penetrate tissue faster and deeper than other antibodies. 2. Easier to use Due to their simple structure, nanobodies also have the advantage of increased stability and ease of use. 3. Easier production When compared to a more traditional antibody, nanobodies are easier to develop and produce in the lab than monoclonal or polyclonal antibodies. 4. More consistent Since nanobodies are recombinantly produced from clonal DNA, you are guaranteed the same product every time. Comparatively, polyclonal antibodies are produced in live animals and have a very low lot-to-lot consistency while monoclonal antibodies can suffer from drift. 5. Higher Affinity Nanobodies benefit from consistently high binding affinity values.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"